Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years. their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing.

Eloret is a chemical vapor sensor that attaches to a cell phone which can be used to accurately sense low levels of various gasses.The chemical sensor project initially was invented by a civil servant at NASA and now being handed over to this company for developing real world applications. This sensor interests the department of homeland security, fire and police departments and medical service providers. They offer research and engineering contract and consulting services to clients in government, industry, and academia. Their area of expertise include aerodynamic design & analysis, high energy fluid dynamics, atmospheric entry, materials characterization and surface science, computational fluid dynamics, ozonation and pollutant formation control, computational chemistry, propulsion, experimental facilities design and analysis, thermal protection materials: development, testing, and model fabrication, experimental fluid dynamics, thermal protection materials: flight test qualification, experimental gas phase and gas-surface chemistry and physical dynamics, wind tunnel/impulse facilities, flowfield diagnostics.

Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.\nGenizon has one of the largest GWAS programs worldwide, addressing many common diseases and traits. Several of these have been successfully completed, generating comprehensive maps of interacting genes, biomarkers and biological disease pathways (known as GeneMaps), providing strong validation of the power of the Company's discovery platform.\nGenizon has out-licensed some of the therapeutic and diagnostic rights to GeneMaps for Crohn's disease (to Genentech) and attention deficit hyperactivity disorder, endometriosis and Alzheimer's disease (disease-state diagnostic rights to Pfizer). GeneMaps have also been generated from GWAS in schizophrenia, psoriasis and longevity. GWAS are in progress for rheumatoid arthritis, Alzheimer's disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension (collectively metabolic syndrome).\nGenizon's technology platform and discoveries can complement current R&D programs by using human genetics to significantly enhance research and by adding value at multiple stages of the drug development process.\nGenizon is continually developing and enhancing its gene and biomarker discovery platform. For example, the company is assessing the role of copy number variations (CNVs) in diseases- applying new methods to ongoing large-scale GWAS in rheumatoid arthritis and metabolic syndrome, and retrospectively to previous studies.\nGenizon also leverages its platform and expertise by offering high throughput, high quality SNP genotyping, statistical genetics, gene expression and pharmacogenomics services to academic institutions, research organizations and the biopharmaceutical industry.

Signosis is a molecular tool company focusing on developing innovative and unique products for biomarker discovery and analysis in life science research, clinic application and drug discovery. Our mission is to become a worldwide provider with a broad spectrum of more sensitive, cost-effective, rapid assay products to target biomarkers such as disease-related proteins, mRNAs, microRNAs, epigenetic variations, and SNP molecular tool innovative biomarker discovery analysis life science research clinic application drug discovery rapid assay disease-related proteins, mRNAs, microRNAs, epigenetic variations, and SNP

Psomagen, Inc., formerly known as Macrogen Corp. The US-based, CLIA and CAP-certified labs of Psomagen are located there. The business is networked in addition to being certified to carry out the best possible Sanger sequencing, Next-Generation Sequencing, and Microarray Gene Analysis.

Curable, Inc. engages in the provision of genome analytics services. Its services include genetic analysis, genetic diagnosis, and development of single nucleotide polymorphism analysis busine diagnostic marker. The company was founded on May 26, 2000 and is headquartered in Seoul, South Korea.

Develops, manufactures, and markets separation technology devices

uBiome, Inc. operates as a biotechnology company. It provides information and tools to explore the populations of bacteria that live on and inside human body. The firm sends customers a kit to collect a tiny stool, mouth, nose, genitals and skin sample and the samples, coupled with a detailed questionnaire, let uBiome's lab compare results with a stockpile of other information from a user database. The company was founded by Zachary Apte and Jessica Richman in November 2012 and is headquartered in San Francisco, CA.

Sapient Discovery is a privately help drug discovery company with proprietary capabilities for discovering novel, patentable small molecule inhibitors, blockers, antagonists, activators or agonists of protein targets independent of disease category. The management and the scientific members have extensive experience in lead discovery and optimization. While the core discovery functions are performed in the U.S., chemistry facilities are utilized from India with their partner companies, Syngene International and Anthem Biosciences. Our technology platform is ideal for very cost-effective drug discovery and has the ability to enable early decision making as to the drugability of protein targets. The company is looking for collaborative opportunities with Biotechnology companies, virtual companies, Pharma companies, non-profit institutes and universities. All the IP rests with the sponsor of our research and any component of lead discovery from Sapient Discovery can be accessed in a fee-for-service fashion. We have completed several SBIR projects and a few are pending. We are currently servicing a few biotechnology companies in antibody structure determination and small molecule-protein crystal structure determination.

Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal's ophthalmic research program is pioneering targeted upstream blockade of pathological angiogenesis through the inhibition of Insulin Receptor Substrate 1 (IRS-1)

Beijing Ao Tejienuo Biotechnology Co., Ltd., established on 2013-08-01, Business scope includes biotechnology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Sell ​​baby products,knitted goods,clothing,shoes and hats,cosmetic,hygiene products,household appliances,daily necessities,Instrumentation,Chemical Products(Free of Hazardous Chemicals,A class of precursor chemicals),electronic product,computer,Software and Auxiliary Equipment,plastic products;Economic Information Consulting;Import and export,Agent import and export,Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sangamo BioSciences is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene. Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks. The blood is sent to a lab which applies the SB-728 treatment to the patient's immune cells. The treatment removes the protein gateway on the immune cells that HIV needs to infect. The treated cells are then infused back into the patient whereby they reproduce and take over as HIV attacks and kills the non-treated cells. The treated, resistant cells thereby control the HIV infection and thus cures the patient from opportunistic infections that result from HIV. Recent published data further support the company's ongoing progress which has been described as "a major step toward immunological functional control of HIV."

Vector Neurosciences, Inc. provides treatment for Parkinson disease. The company was founded by Michael Kaplitt and is headquartered in Wilmington, DE.

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

Wholesales and distributes nutritional products for the pig, poultry and ruminant sectors

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Siemens Medical Solutions USA, Inc. provides medical products and solutions. It offers imaging systems, therapy equipment, and hearing instruments for diagnosis, treatments, and patient monitoring. The firm services include imaging and therapy, customer resources and logins, healthcare financing solutions and laboratory diagnostics services. The company was founded in 1896 and is headquartered in Malvern, PA.